Roland Brock

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Topics

Mesenchymal Stem Cells

Top Venues

Bioconjugate chemistry

Small (Weinheim an der Bergstrasse, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Kim E de Roode, Khadijeh Hashemi, Wouter P R Verdurmen, Roland Brock
Tumor-On-A-Chip Models for Predicting In Vivo Nanoparticle Behavior. Small (Weinheim an der Bergstrasse, Germany) 20 (35) (2024)
Kim E de Roode, Khadijeh Hashemi, Wouter P R Verdurmen, Roland Brock
Tumor-On-A-Chip Models for Predicting In Vivo Nanoparticle Behavior. Small (Weinheim an der Bergstrasse, Germany) (2024)
Lea Andrée, Rik Oude Egberink, Renée Heesakkers, Ceri-Anne E Suurmond, Lucas S Joziasse, Masoomeh Khalifeh, Rong Wang, Fang Yang, Roland Brock, Sander C G Leeuwenburgh
Local mRNA Delivery from Nanocomposites Made of Gelatin and Hydroxyapatite Nanoparticles. ACS applied materials & interfaces (2024)
Rik Oude Egberink, Alexander H van Asbeck, Milou Boswinkel, Grigor Muradjan, Jürgen Dieker, Roland Brock
Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery. Bioconjugate chemistry (2023)
Maria V Luna-Velez, Omar Paulino da Silva Filho, Gerald W Verhaegh, Onno van Hooij, Najoua El Boujnouni, Roland Brock, Jack A Schalken
Delivery of antisense oligonucleotides for splice-correction of androgen receptor pre-mRNA in castration-resistant prostate cancer models using cell-penetrating peptides. The Prostate 82 (6) (2022)
Estel Collado Camps, Sanne A M van Lith, Annemarie Kip, Cathelijne Frielink, Lieke Joosten, Roland Brock, Martin Gotthardt
Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39). European journal of nuclear medicine and molecular imaging (2022)
Tjessa Bondue, Lambertus P W J van den Heuvel, Levtchenko Elena, Roland Brock
The potential of RNA-based therapy for kidney diseases. Pediatric nephrology (Berlin, Germany) (2022)
Omar Paulino da Silva Filho, Muhanad Ali, Rike Nabbefeld, Daniel Primavessy, Petra H Bovee-Geurts, Silko Grimm, Andreas Kirchner, Karl-Heinz Wiesmüller, Marc Schneider, X Frank Walboomers, Roland Brock
A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG-PLGA nanoparticles with a cell-penetrating peptide. RSC advances 11 (57) (2021)
Natalia Feiner-Gracia, R Alis Olea, Robert Fitzner, Najoua El Boujnouni, Alexander H van Asbeck, Roland Brock, Lorenzo Albertazzi
Super-resolution Imaging of Structure, Molecular Composition, and Stability of Single Oligonucleotide Polyplexes. Nano letters 19 (5) (2019)
Celine Bolwerk, Larissa P M W D Govers, Hanna Knol, Thom F Oostendorp, Roland Brock
Modeling the Accumulation of Degradable Polymer Drug Carriers in the Brain. ChemMedChem 13 (13) (2018)
Rike Wallbrecher, Patrick Chène, Stephan Ruetz, Therese Stachyra, Thomas Vorherr, Roland Brock
A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors. British journal of pharmacology 174 (16) (2017)
Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich
Lactam-Stapled Cell-Penetrating Peptides: Cell Uptake and Membrane Binding Properties. Journal of medicinal chemistry 60 (19) (2017)
Dirk van den Brand, Leon F Massuger, Roland Brock, Wouter P R Verdurmen
Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs. Bioconjugate chemistry 28 (3) (2017)
Samuel Schmidt, Merel J W Adjobo-Hermans, Robin Kohze, Thilo Enderle, Roland Brock, Francesca Milletti
Identification of Short Hydrophobic Cell-Penetrating Peptides for Cytosolic Peptide Delivery by Rational Design. Bioconjugate chemistry 28 (2) (2016)